Goldman Sachs Downgrades Dr. Pepper Snapple to Sell (DPS)

Goldman Sachs is out with its report today on Dr. Pepper Snapple DPS, downgrading shares of DPS from Neutral to Sell. In a note to clients, Goldman Sachs writes, "We are downgrading shares of Dr Pepper Snapple Group to Sell from Neutral as we expect shares to underperform our coverage universe in the near-term. We are lowering estimates to reflect higher than expected cost inflation and now see downside risk to consensus estimates in 1H11." At the time of posting, shares of DPS were trading pre-market at $36.75, down 1.90% from Friday's close.